1.
A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s
disease chromosomes. The Huntington’s Disease Collaborative Research Group. Cell.
1993 Mar 26;72(6):971–83.
2.
Ross CA, Aylward EH, Wild EJ, Langbehn DR, Long JD, Warner JH, et al. Huntington disease:
natural history, biomarkers and prospects for therapeutics. Nature Reviews Neurology.
2014 Apr;10(4):204–16.
3.
Roos RAC. Huntington’s disease: a clinical review. Orphanet Journal of Rare Diseases.
2010;5(1):40.
4.
The U.S.-Venezuela Collaborative, Wexler NS, Lorimer J, Porter J, Gomez F, Moskowitz
C, et al. Venezuelan kindreds reveal that genetic and environmental factors modulate
Huntington’s disease age of onset. Proceedings of the National Academy of Sciences.
2004 Mar 9;101(10):3498–503.
5.
Lee J-M, Wheeler VC, Chao MJ, Vonsattel JPG, Pinto RM, Lucente D, et al. Identification
of genetic factors that modify clinical onset of Huntington’s disease. Cell. 2015
Jul;162(3):516–26.
6.
Dorsey ER, the Huntington Study Group COHORT Investigators. Characterization of a
large group of individuals with Huntington disease and their relatives enrolled in
the COHORT study. Lewin A, editor. PLoS ONE. 2012 Feb 16;7(2):e29522.
7.
Wu Z-Y, Xu M. Huntington disease in Asia. Chinese Medical Journal. 2015;128(13):1815.
8.
Murgod UA, Saleem Q, Anand A, Brahmachari SK, Jain S, Muthane UB. A clinical study
of patients with genetically confirmed Huntington’s disease from India. J Neurol Sci.
2001 Sep 15;190(1–2):73–8.
9.
Saleem Q, Roy S, Murgood U, Saxena R, Verma IC, Anand A, et al. Molecular analysis
of Huntington’s disease and linked polymorphisms in the Indian population. Acta Neurol
Scand. 2003 Oct;108(4):281–6.
10.
Chheda P, Chanekar M, Salunkhe Y, Dama T, Pais A, Pande S, et al. A Study of triplet-primed
PCR for identification of CAG repeat expansion in the HTT gene in a cohort of 503
Indian cases with Huntington’s disease symptoms. Molecular Diagnosis & Therapy. 2018
Jun;22(3):353–9.
12.
Chhuttani PN. Huntington’s chorea in India. J Indian Med Assoc. 1957 Aug 16;29(4):156–7.
13.
Lenka A, Kamble NL, Sowmya V, Jhunjhunwala K, Yadav R, Netravathi M, et al. Determinants
of onset of Huntington’s disease with behavioral symptoms: Insight from 92 patients.
Journal of Huntington’s Disease. 2015 Dec 11;4(4):319–24.
14.
Moily NS, Kota LN, Anjanappa RM, Venugopal S, Vaidyanathan R, Pal P, et al. Trinucleotide
repeats and haplotypes at the Huntingtin locus in an Indian sample overlaps with European
haplogroup A. PLoS Currents [Internet]. 2014. Available from: http://currents.plos.org/hd/?p=10561
15.
Unified Huntington’s disease rating scale: Reliability and consistency. Movement Disorders.
1996 Mar;11(2):136–42.
16.
Shoulson I, Fahn S. Huntington disease: clinical care and evaluation. Neurology. 1979
Jan;29(1):1–3.
17.
Rawlins MD, Wexler NS, Wexler AR, Tabrizi SJ, Douglas I, Evans SJW, et al. The Prevalence
of Huntington’s Disease. Neuroepidemiology. 2016;46(2):144–53.
18.
Rodrigues FB, Abreu D, Damásio J, Goncalves N, Correia-Guedes L, Coelho M, et al.
Survival, mortality, causes and places of death in a European Huntington’s disease
prospective cohort. Movement Disorders Clinical Practice. 2017 Sep;4(5):737–42.
19.
Paoli R, Botturi A, Ciammola A, Silani V, Prunas C, Lucchiari C, et al. Neuropsychiatric
burden in Huntington’s disease. Brain Sciences. 2017 Jun 16;7(12):67.
20.
Wetzel HH, Gehl CR, Dellefave–Castillo L, Schiffman JF, Shannon KM, Paulsen JS. Suicidal
ideation in Huntington disease: The role of comorbidity. Psychiatry Research. 2011
Aug;188(3):372–6.
21.
Hubers AAM, van Duijn E, Roos RAC, Craufurd D, Rickards H, Bernhard Landwehrmeyer
G, et al. Suicidal ideation in a European Huntington’s disease population. Journal
of Affective Disorders. 2013 Oct;151(1):248–58.
22.
Radhakrishnan R, Andrade C. Suicide: An Indian perspective. Indian Journal of Psychiatry.
2012;54(4):304.
23. The Enroll-HD investigators, Honrath P, Dogan I, Wudarczyk O, Görlich KS, Votinov
M, et al. Risk factors of suicidal ideation in Huntington’s disease: literature review
and data from Enroll-HD. Journal of Neurology. 2018 Nov;265(11):2548–61.
24.
van Duijn E, Craufurd D, Hubers AAM, Giltay EJ, Bonelli R, Rickards H, et al. Neuropsychiatric
symptoms in a European Huntington’s disease cohort (REGISTRY). Journal of Neurology,
Neurosurgery & Psychiatry. 2014 Dec;85(12):1411–8.
25. Paulsen JS, Ready RE, Hamilton JM, Mega MS, Cummings JL. Neuropsychiatric aspects
of Huntington's disease. Journal of Neurology, Neurosurgery & Psychiatry. 2001 Sep
1;71(3):310-4.
26.
Naarding P, Janzing JGE, Eling P, van der Werf S, Kremer B. Apathy is not depression
in Huntington’s disease. The Journal of Neuropsychiatry and Clinical Neurosciences.
2009 Jul;21(3):266–70.
27.
Reddy VM, Chandrashekar CR. Prevalence of mental and behavioural disorders in India :
a meta-analysis. Indian J Psychiatry. 1998 Apr;40(2):149–57.
28.
Peavy GM, Jacobson MW, Goldstein JL, Hamilton JM, Kane A, Gamst AC, et al. Cognitive
and functional decline in Huntington’s disease: dementia criteria revisited. Mov Disord.
2010 Jul 15;25(9):1163–9.
29.
Stewart C. Dysphagia symptoms and treatment in Huntington’s disease: Review. Perspectives
on Swallowing and Swallowing Disorders (Dysphagia). 2012 Dec 1;21(4):126.
30.
Marder K, Zhao H, Myers RH, Cudkowicz M, Kayson E, Kieburtz K, et al. Rate of functional
decline in Huntington’s disease. Huntington Study Group. Neurology. 2000 Jan 25;54(2):452–8.
31.
Frich JC, Rae D, Roxburgh R, Miedzybrodzka ZH, Edmondson M, Pope EB, et al. Health
care delivery practices in Huntington’s disease specialty clinics: An international
survey. Journal of Huntington’s Disease. 2016 Jul 1;5(2):207–13.
32.
Skirton H, Williams JK, Jackson Barnette J, Paulsen JS. Huntington disease: families’
experiences of healthcare services. J Adv Nurs. 2010 Mar;66(3):500–10.